MedPath

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase 3
Completed
Conditions
Plaque Psoriasis
Interventions
Biological: ABT-874
Drug: Placebo
Registration Number
NCT00570986
Lead Sponsor
AbbVie (prior sponsor, Abbott)
Brief Summary

The purpose of this study is to determine the safety and efficacy of 2 doses of ABT-874 versus placebo in the treatment of subjects with moderate to severe plaque psoriasis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1465
Inclusion Criteria
  • Subject is >= 18 years of age
  • Subject had a clinical diagnosis of psoriasis for at least 6 months, and had moderate to severe plaque psoriasis
  • Subject is judged to be in generally good health as determined by the principal investigator
Exclusion Criteria
  • Subject has previous exposure to systemic anti-IL 12 therapy
  • Subject cannot discontinue systemic therapies and/or topical therapies for the treatment of psoriasis and cannot avoid UVB or PUVA phototherapy
  • Subject is taking or requires oral or injectible corticosteroids
  • Subject diagnosed with erythrodermic psoriasis, pustular psoriasis, medication-induced or medication-exacerbated psoriasis or new onset guttate psoriasis
  • Subject considered by the investigator, for any reason, to be an unsuitable candidate
  • Female subject who is pregnant or breast-feeding or considering becoming pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2ABT-874Arm #2 is used for entire study. At week 12, arm is rerandomized.
3ABT-874Arm #3 is not used for weeks 0-11. At week 12, arm is rerandomized.
1PlaceboArm #1 is used for entire study. At week 12, arm is rerandomized.
Primary Outcome Measures
NameTimeMethod
PGAProportion of subjects maintaining a PGA 0/1 response at Week 52
PASISubjects achieving a PASI 75 response defined as a 75% reduction in the PASI score from baseline at Week 12
Secondary Outcome Measures
NameTimeMethod
PASISubjects who achieve PASI 90 and 100 at Week 12
NAPSI% change in NAPSI score at Week 12 vs placebo in subjects with nail psoriasis
DLQIChange from Baseline in DLQI total score vs. placebo at Week 12
Safety parametersThroughout study

Trial Locations

Locations (116)

Site Reference ID/Investigator# 7165

🇺🇸

Columbus, Ohio, United States

Site Reference ID/Investigator# 6822

🇺🇸

Dallas, Texas, United States

Site Reference ID/Investigator# 6712

🇺🇸

Philadelphia, Pennsylvania, United States

Site Reference ID/Investigator# 7067

🇨🇦

Waterloo, Canada

Site Reference ID/Investigator# 8139

🇺🇸

Torrance, California, United States

Site Reference ID/Investigator# 7167

🇺🇸

Vallejo, California, United States

Site Reference ID/Investigator# 7016

🇺🇸

South Miami, Florida, United States

Site Reference ID/Investigator# 6584

🇺🇸

Tucson, Arizona, United States

Site Reference ID/Investigator# 7669

🇺🇸

Oceanside, California, United States

Site Reference ID/Investigator# 6702

🇨🇦

Edmonton, Canada

Site Reference ID/Investigator# 6581

🇺🇸

Fridley, Minnesota, United States

Site Reference ID/Investigator# 6826

🇺🇸

Fort Gratiot, Michigan, United States

Site Reference ID/Investigator# 6709

🇺🇸

St. Louis, Missouri, United States

Site Reference ID/Investigator# 7989

🇺🇸

Grand Blanc, Michigan, United States

Site Reference ID/Investigator# 7309

🇨🇦

Hamilton, Canada

Site Reference ID/Investigator# 6825

🇺🇸

Arlington, Texas, United States

Site Reference ID/Investigator# 6588

🇨🇦

Laval, Canada

Site Reference ID/Investigator# 6703

🇺🇸

Boston, Massachusetts, United States

Site Reference ID/Investigator# 7878

🇺🇸

Buffalo, New York, United States

Site Reference ID/Investigator# 7876

🇺🇸

New York, New York, United States

Site Reference ID/Investigator# 6710

🇺🇸

Fresno, California, United States

Site Reference ID/Investigator# 6591

🇺🇸

Bakersfield, California, United States

Site Reference ID/Investigator# 7885

🇺🇸

Irvine, California, United States

Site Reference ID/Investigator# 6872

🇺🇸

Los Angeles, California, United States

Site Reference ID/Investigator# 6711

🇺🇸

Santa Monica, California, United States

Site Reference ID/Investigator# 6921

🇺🇸

Longmont, Colorado, United States

Site Reference ID/Investigator# 7450

🇺🇸

Atlanta, Georgia, United States

Site Reference ID/Investigator# 6717

🇺🇸

Snellville, Georgia, United States

Site Reference ID/Investigator# 7877

🇺🇸

Maywood, Illinois, United States

Site Reference ID/Investigator# 7017

🇺🇸

Arlington Heights, Illinois, United States

Site Reference ID/Investigator# 6704

🇺🇸

Skokie, Illinois, United States

Site Reference ID/Investigator# 7292

🇺🇸

West Dundee, Illinois, United States

Site Reference ID/Investigator# 7646

🇺🇸

Indianapolis, Indiana, United States

Site Reference ID/Investigator# 7523

🇺🇸

Owensboro, Kentucky, United States

Site Reference ID/Investigator# 6597

🇺🇸

Andover, Massachusetts, United States

Site Reference ID/Investigator# 7890

🇺🇸

St. Louis, Missouri, United States

Site Reference ID/Investigator# 7299

🇺🇸

Berlin, New Jersey, United States

Site Reference ID/Investigator# 6924

🇺🇸

East Windsor, New Jersey, United States

Site Reference ID/Investigator# 6577

🇺🇸

New Brunswick, New Jersey, United States

Site Reference ID/Investigator# 6821

🇺🇸

San Diego, California, United States

Site Reference ID/Investigator# 6832

🇺🇸

San Diego, California, United States

Site Reference ID/Investigator# 7305

🇺🇸

San Diego, California, United States

Site Reference ID/Investigator# 7301

🇺🇸

Miami, Florida, United States

Site Reference ID/Investigator# 7012

🇺🇸

Miami, Florida, United States

Site Reference ID/Investigator# 6831

🇺🇸

Miami, Florida, United States

Site Reference ID/Investigator# 6706

🇺🇸

Indianapolis, Indiana, United States

Site Reference ID/Investigator# 6705

🇺🇸

Houston, Texas, United States

Site Reference ID/Investigator# 7030

🇺🇸

Albuquerque, New Mexico, United States

Site Reference ID/Investigator# 6895

🇺🇸

New York, New York, United States

Site Reference ID/Investigator# 6599

🇺🇸

New York, New York, United States

Site Reference ID/Investigator# 7637

🇺🇸

New York, New York, United States

Site Reference ID/Investigator# 7293

🇺🇸

Wilmington, North Carolina, United States

Site Reference ID/Investigator# 7504

🇺🇸

Rochester, New York, United States

Site Reference ID/Investigator# 7018

🇺🇸

Stoney Brook, New York, United States

Site Reference ID/Investigator# 6926

🇺🇸

Hickory, North Carolina, United States

Site Reference ID/Investigator# 6598

🇺🇸

Cincinnati, Ohio, United States

Site Reference ID/Investigator# 8082

🇺🇸

Cleveland, Ohio, United States

Site Reference ID/Investigator# 7659

🇺🇸

Dayton, Ohio, United States

Site Reference ID/Investigator# 6727

🇺🇸

Lake Oswego, Oregon, United States

Site Reference ID/Investigator# 7879

🇺🇸

Hershey, Pennsylvania, United States

Site Reference ID/Investigator# 6580

🇺🇸

Johnston, Rhode Island, United States

Site Reference ID/Investigator# 6576

🇺🇸

Providence, Rhode Island, United States

Site Reference ID/Investigator# 6589

🇺🇸

Greer, South Carolina, United States

Site Reference ID/Investigator# 6586

🇺🇸

Goodlettsville, Tennessee, United States

Site Reference ID/Investigator# 7668

🇺🇸

Knoxville, Tennessee, United States

Site Reference ID/Investigator# 7671

🇺🇸

Dallas, Texas, United States

Site Reference ID/Investigator# 6912

🇺🇸

Tyler, Texas, United States

Site Reference ID/Investigator# 7306

🇺🇸

Webster, Texas, United States

Site Reference ID/Investigator# 6807

🇺🇸

Norfolk, Virginia, United States

Site Reference ID/Investigator# 6801

🇺🇸

Seattle, Washington, United States

Site Reference ID/Investigator# 7519

🇺🇸

Spokane, Washington, United States

Site Reference ID/Investigator# 7314

🇨🇦

Barrie, Canada

Site Reference ID/Investigator# 7452

🇨🇦

Calgary, Canada

Site Reference ID/Investigator# 6715

🇨🇦

London, Canada

Site Reference ID/Investigator# 7315

🇨🇦

London, Canada

Site Reference ID/Investigator# 7636

🇨🇦

Markham, Canada

Site Reference ID/Investigator# 6699

🇨🇦

Montreal, Canada

Site Reference ID/Investigator# 7316

🇨🇦

Montreal, Canada

Site Reference ID/Investigator# 7088

🇨🇦

North Bay, Canada

Site Reference ID/Investigator# 7310

🇨🇦

Ottawa, Canada

Site Reference ID/Investigator# 7311

🇨🇦

Quebec City, Canada

Site Reference ID/Investigator# 6708

🇺🇸

San Antonio, Texas, United States

Site Reference ID/Investigator# 7081

🇺🇸

San Antonio, Texas, United States

Site Reference ID/Investigator# 7313

🇨🇦

St. John's, Canada

Site Reference ID/Investigator# 7308

🇨🇦

Vancouver, Canada

Site Reference ID/Investigator# 6713

🇨🇦

Vancouver, Canada

Site Reference ID/Investigator# 7087

🇨🇦

Windsor, Canada

Site Reference ID/Investigator# 7312

🇨🇦

Westmount, Canada

Site Reference ID/Investigator# 6805

🇨🇦

Windsor, Canada

Site Reference ID/Investigator# 7014

🇺🇸

Overland Park, Kansas, United States

Site Reference ID/Investigator# 7990

🇺🇸

San Francisco, California, United States

Site Reference ID/Investigator# 6915

🇺🇸

Nashville, Tennessee, United States

Site Reference ID/Investigator# 8101

🇺🇸

Salt Lake City, Utah, United States

Site Reference ID/Investigator# 6579

🇺🇸

Birmingham, Alabama, United States

Site Reference ID/Investigator# 6697

🇺🇸

Birmingham, Alabama, United States

Site Reference ID/Investigator# 7644

🇺🇸

Detroit, Michigan, United States

Site Reference ID/Investigator# 7302

🇺🇸

Denver, Colorado, United States

Site Reference ID/Investigator# 6894

🇺🇸

Portland, Oregon, United States

Site Reference ID/Investigator# 6578

🇺🇸

Portland, Oregon, United States

Site Reference ID/Investigator# 7295

🇺🇸

Portland, Oregon, United States

Site Reference ID/Investigator# 6716

🇨🇦

Halifax, Canada

Site Reference ID/Investigator# 7317

🇨🇦

Surrey, Canada

Site Reference ID/Investigator# 7638

🇨🇦

Winnipeg, Canada

Site Reference ID/Investigator# 7451

🇺🇸

Omaha, Nebraska, United States

Site Reference ID/Investigator# 7080

🇺🇸

Milwaukee, Wisconsin, United States

Site Reference ID/Investigator# 7015

🇺🇸

Huntsville, Alabama, United States

Site Reference ID/Investigator# 6707

🇺🇸

Jacksonville, Florida, United States

Site Reference ID/Investigator# 6582

🇺🇸

Alpharetta, Georgia, United States

Site Reference ID/Investigator# 6590

🇺🇸

West Palm Beach, Florida, United States

Site Reference ID/Investigator# 6714

🇺🇸

Newnan, Georgia, United States

Site Reference ID/Investigator# 8251

🇺🇸

Winston-Salem, North Carolina, United States

Site Reference ID/Investigator# 6696

🇺🇸

Little Rock, Arkansas, United States

Site Reference ID/Investigator# 6728

🇺🇸

Scottsdale, Arizona, United States

Site Reference ID/Investigator# 6873

🇺🇸

Louisville, Kentucky, United States

Site Reference ID/Investigator# 6917

🇺🇸

New Haven, Connecticut, United States

Site Reference ID/Investigator# 6762

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath